178 related articles for article (PubMed ID: 19261438)
21. Anatomical-based FDG-PET reconstruction for the detection of hypo-metabolic regions in epilepsy.
Baete K; Nuyts J; Van Paesschen W; Suetens P; Dupont P
IEEE Trans Med Imaging; 2004 Apr; 23(4):510-9. PubMed ID: 15084076
[TBL] [Abstract][Full Text] [Related]
22. Partial volume correction of standardized uptake values and the dual time point in FDG-PET imaging: should these be routinely employed in assessing patients with cancer?
Basu S; Alavi A
Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1527-9. PubMed ID: 17522857
[No Abstract] [Full Text] [Related]
23. Quantification in clinical fluorodeoxyglucose positron emission tomography.
Hallett WA
Nucl Med Commun; 2004 Jul; 25(7):647-50. PubMed ID: 15208490
[TBL] [Abstract][Full Text] [Related]
24. Characterization of the image-derived carotid artery input function using independent component analysis for the quantitation of [18F] fluorodeoxyglucose positron emission tomography images.
Chen K; Chen X; Renaut R; Alexander GE; Bandy D; Guo H; Reiman EM
Phys Med Biol; 2007 Dec; 52(23):7055-71. PubMed ID: 18029993
[TBL] [Abstract][Full Text] [Related]
25. Impact of reversible trapping of tracer and the presence of blood metabolites on measurements of myocardial glucose utilization performed by PET and 18F-fluorodeoxyglucose using the Patlak method.
Herrero P; Dence CS; Sharp TL; Welch MJ; Gropler RJ
Nucl Med Biol; 2004 Oct; 31(7):883-92. PubMed ID: 15464390
[TBL] [Abstract][Full Text] [Related]
26. Shortened acquisition protocols for the quantitative assessment of the 2-tissue-compartment model using dynamic PET/CT 18F-FDG studies.
Strauss LG; Pan L; Cheng C; Haberkorn U; Dimitrakopoulou-Strauss A
J Nucl Med; 2011 Mar; 52(3):379-85. PubMed ID: 21321263
[TBL] [Abstract][Full Text] [Related]
27. A consistent and efficient graphical analysis method to improve the quantification of reversible tracer binding in radioligand receptor dynamic PET studies.
Zhou Y; Ye W; Brasić JR; Crabb AH; Hilton J; Wong DF
Neuroimage; 2009 Feb; 44(3):661-70. PubMed ID: 18930830
[TBL] [Abstract][Full Text] [Related]
28. Extraction of a plasma time-activity curve from dynamic brain PET images based on independent component analysis.
Naganawa M; Kimura Y; Ishii K; Oda K; Ishiwata K; Matani A
IEEE Trans Biomed Eng; 2005 Feb; 52(2):201-10. PubMed ID: 15709657
[TBL] [Abstract][Full Text] [Related]
29. Quantitative brain FDG/PET studies using dynamic aortic imaging.
Dhawan V; Takikawa S; Robeson W; Spetsieris P; Chaly T; Dahl R; Zanzi I; Bandyopadhyay D; Margouleff D; Eidelberg D
Phys Med Biol; 1994 Sep; 39(9):1475-87. PubMed ID: 15552117
[TBL] [Abstract][Full Text] [Related]
30. A 5D computational phantom for pharmacokinetic simulation studies in dynamic emission tomography.
Kotasidis FA; Tsoumpas C; Polycarpou I; Zaidi H
Comput Med Imaging Graph; 2014 Dec; 38(8):764-73. PubMed ID: 25082066
[TBL] [Abstract][Full Text] [Related]
31. Quantification in positron emission tomography for research in pharmacology and drug development.
Cunningham VJ; Gunn RN; Matthews JC
Nucl Med Commun; 2004 Jul; 25(7):643-6. PubMed ID: 15208489
[TBL] [Abstract][Full Text] [Related]
32. Parametric imaging: a promising approach for the evaluation of dynamic PET-18F-FDG studies - the DKFZ experience.
Dimitrakopoulou-Strauss A; Pan L; Strauss LG
Hell J Nucl Med; 2010; 13(1):18-22. PubMed ID: 20411165
[TBL] [Abstract][Full Text] [Related]
33. FDG-PET-based differential uptake volume histograms: a possible approach towards definition of biological target volumes.
Devic S; Mohammed H; Tomic N; Aldelaijan S; De Blois F; Seuntjens J; Lehnert S; Faria S
Br J Radiol; 2016 Jun; 89(1062):20150388. PubMed ID: 27007269
[TBL] [Abstract][Full Text] [Related]
34. Annihilation photon acollinearity in PET: volunteer and phantom FDG studies.
Shibuya K; Yoshida E; Nishikido F; Suzuki T; Tsuda T; Inadama N; Yamaya T; Murayama H
Phys Med Biol; 2007 Sep; 52(17):5249-61. PubMed ID: 17762084
[TBL] [Abstract][Full Text] [Related]
35. Effect of MRI acoustic noise on cerebral fludeoxyglucose uptake in simultaneous MR-PET imaging.
Chonde DB; Abolmaali N; Arabasz G; Guimaraes AR; Catana C
Invest Radiol; 2013 May; 48(5):302-12. PubMed ID: 23462677
[TBL] [Abstract][Full Text] [Related]
36. Reliability of semiquantitative ¹⁸F-FDG PET parameters derived from simultaneous brain PET/MRI: a feasibility study.
Jena A; Taneja S; Goel R; Renjen P; Negi P
Eur J Radiol; 2014 Jul; 83(7):1269-1274. PubMed ID: 24813529
[TBL] [Abstract][Full Text] [Related]
37. Age-related metabolic profiles in cognitively healthy elders: results from a voxel-based [18F]fluorodeoxyglucose-positron-emission tomography study with partial volume effects correction.
Curiati PK; Tamashiro-Duran JH; Duran FL; Buchpiguel CA; Squarzoni P; Romano DC; Vallada H; Menezes PR; Scazufca M; Busatto GF; Alves TC
AJNR Am J Neuroradiol; 2011 Mar; 32(3):560-5. PubMed ID: 21273352
[TBL] [Abstract][Full Text] [Related]
38. Novel assessment of global metabolism by 18F-FDG-PET for localizing affected lobe in temporal lobe epilepsy.
Peter J; Houshmand S; Werner TJ; Rubello D; Alavi A
Nucl Med Commun; 2016 Aug; 37(8):882-7. PubMed ID: 27092666
[TBL] [Abstract][Full Text] [Related]
39. Super-resolution in PET imaging.
Kennedy JA; Israel O; Frenkel A; Bar-Shalom R; Azhari H
IEEE Trans Med Imaging; 2006 Feb; 25(2):137-47. PubMed ID: 16468448
[TBL] [Abstract][Full Text] [Related]
40. Whole-body 18F-FDG PET/CT in the presence of truncation artifacts.
Beyer T; Bockisch A; Kühl H; Martinez MJ
J Nucl Med; 2006 Jan; 47(1):91-9. PubMed ID: 16391192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
